tafasitamab

Spain

Drugs containing this active substance

  • MINJUVI 200 MG POWDER FOR CONCENTRATE FOR INFUSION SOLUTION

    It is used to treat adults with certain blood cancers that affect B lymphocytes (diffuse large B-cell lymphoma and follicular lymphoma), specifically when the cancer has recurred or has not responded to previous treatments.

    Form: powder for concentrate for solution for infusion

    Active substance Dosage
    tafasitamab 200 mg

    ATC: L01F L01FX L01FX12

    Manufacturer: Incyte Biosciences Distribution B.V.